El Salvador vs Micronesia, Federated States of: Hypertension among adults aged 30-79 years, prevalence
El Salvador
32.7
in 2019
Micronesia, Federated States of
32.9
in 2019
El Salvador rank
141st
Micronesia, Federated States of rank
139th
Hypertension among adults aged 30-79 years, prevalence over time
- El Salvador
- Micronesia, Federated States of
How they compare
Micronesia, Federated States of currently reports 32.9 against 32.7 in El Salvador, a difference of 0.2.
The two have swapped places 2 times across 30 shared years of data; in 1990 it was Micronesia, Federated States of ahead.
El Salvador ranks 141st and Micronesia, Federated States of ranks 139th of 193 countries.
Across the 3 decades both report, El Salvador averaged higher in 2 and Micronesia, Federated States of in 1.
Head to head by decade
| Decade | El Salvador | Micronesia, Federated States of | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 28.86 | 29.92 | 1.06 | Micronesia, Federated States of |
| 2000s | 30.57 | 29.79 | 0.78 | El Salvador |
| 2010s | 32.28 | 32.12 | 0.16 | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension among adults aged 30-79 years, prevalence, El Salvador or Micronesia, Federated States of?
- Micronesia, Federated States of, at 32.9 against 32.7 in El Salvador as of 2019.
- What is the difference in hypertension among adults aged 30-79 years, prevalence between El Salvador and Micronesia, Federated States of?
- 0.2, with Micronesia, Federated States of ahead.
- How many years of comparable data are there for El Salvador and Micronesia, Federated States of?
- 30 years are reported by both, from 1990 to 2019.
- How do El Salvador and Micronesia, Federated States of rank globally for hypertension among adults aged 30-79 years, prevalence?
- El Salvador ranks 141st and Micronesia, Federated States of ranks 139th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension among adults aged 30-79 years, prevalence, age-standardized. Statizoid refreshes it automatically from the source and publishes the full history for both places.